1-6 of 6
Laura Evgin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium

Christopher Alvarez-Breckenridge, Kristin G. Anderson, Ana Luisa Correia, Shadmehr Demehri, Huy Q. Dinh, Karen Olivia Dixon, Gavin P. Dunn, Laura Evgin, Jeremy Goc, Zinaida Good, Nir Hacohen, Patrick Han, Pavel Hanč, John Hickey, Kelly Kersten, Beiyun C. Liu, Aitziber Buque, Yuxuan ‘Phoenix’ Miao, J. Justin Milner, Yuri Pritykin, Ferdinando Pucci, Nicole E. Scharping, Lisa Sudmeier, Yufei Wang, Andreas Wieland, Michelle M. Williams
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (12): 1571–1577.
https://doi.org/10.1158/2326-6066.CIR-23-0522
Published: 01 December 2023
View articletitled, Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium
Open the PDF for Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium in another window
Journal Articles

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment

Laura Evgin, Amanda L. Huff, Timothy Kottke, Jill Thompson, Amy M. Molan, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Phonphimon Wongthida, Elizabeth J. Ilett, Karen Kaluza Smith, Reuben S. Harris, Matt Coffey, Jose S. Pulido, Hardev Pandha, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Richard G. Vile
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (5): 828–840.
https://doi.org/10.1158/2326-6066.CIR-18-0013
Published: 01 May 2019
View articletitled, Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment
Open the PDF for Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment in another window
Includes: Supplementary data
Journal Articles

Abstract B138: Cancer immunotherapy with APOBEC3B-induced heteroclitic library tumor cell vaccines and immune checkpoint blockade

Richard Vile, Laura Evgin, Timothy Kottke, Matthew Schuelke, Christopher B. Driscoll, Amanda L. Huff, Jill Thompson, Amy Molan, Reuben S. Harris, Jose S. Pulido, Phonphimon Wongthida
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B138.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B138
Published: 01 February 2019
View articletitled, Abstract B138: Cancer immunotherapy with APOBEC3B-induced heteroclitic library tumor cell vaccines and immune checkpoint blockade
Journal Articles

Abstract A133: APOBEC3 confers resistance to oncolytic VSV therapy

Amanda L. Huff, Phonphimon Wongthida, Timothy Kottke, Jill Thompson, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Reuben S. Harris, Amy Molan, Jose S. Pulido, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Laura Evgin, Richard Vile
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A133.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A133
Published: 01 February 2019
View articletitled, Abstract A133: APOBEC3 confers resistance to oncolytic VSV therapy
Journal Articles

Abstract A029: Unexpected antagonism between oncolytic virus derived type I interferon and EGFRvIII CAR T-cells

Laura Evgin, Amanda L. Huff, Phonphimon Wongthida, Jill Thompson, Timothy Kottke, John Sampson, Luis Sanchez Perez, Richard Vile
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A029.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A029
Published: 01 February 2019
View articletitled, Abstract A029: Unexpected antagonism between oncolytic virus derived type I interferon and EGFRvIII CAR T-cells
Journal Articles

Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence

Tim Kottke, Laura Evgin, Kevin G. Shim, Diana Rommelfanger, Nicolas Boisgerault, Shane Zaidi, Rosa Maria Diaz, Jill Thompson, Elizabeth Ilett, Matt Coffey, Peter Selby, Hardev Pandha, Kevin Harrington, Alan Melcher, Richard Vile
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (11): 1029–1045.
https://doi.org/10.1158/2326-6066.CIR-17-0175
Published: 31 October 2017
View articletitled, Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence
Open the PDF for Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence in another window